About: MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 03 April 2008

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2008 (fr) наукова стаття, опублікована в березні 2009 (uk) im März 2009 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 2008 (ast) scientific article published on 03 April 2008 (en)
publication date	wds:Q56974121-B8BE10F1-4A22-42AF-BEA0-37509AE62936
publication date	2008-04-03 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56974121-3B209681-A84A-4479-A5F0-6C171DA4E574
language of work or name	English
author name string	wds:Q56974121-0E710E0E-3C19-4308-9500-BA3FBB27257E wds:Q56974121-19678004-DA66-41A1-AEB9-E45790F36E3D wds:Q56974121-1A351B62-9012-4B44-964F-B6C76A61BD53 wds:Q56974121-38B6B3C4-14C6-4CD4-B31E-13B1A3DF2693 wds:Q56974121-3AF5B6FA-18A3-4AEE-BC4A-5AFEAEFE4717 wds:Q56974121-52363594-AA1A-435D-AC0D-DA1C17F6DF9E wds:Q56974121-59559700-D2A4-48DC-ACF1-BC78B90BAE5A wds:Q56974121-816F5814-82EB-47F1-9FCF-9421E0AB265C wds:Q56974121-8722394A-B7FE-45D0-8072-26EAE1DFB966 wds:Q56974121-95301625-04A4-4C13-A85B-C9B1757A4083 wds:Q56974121-A452BEE4-9402-446B-864C-459934C192E8 wds:Q56974121-AC03F602-8DB9-460F-8297-E7C105387472 wds:Q56974121-AD2A80C6-25FE-4D18-9A34-8378BB0F7924 wds:Q56974121-B692FA8A-564B-4770-9589-D2E41DCA1DD5 wds:Q56974121-BC25BA4C-B764-485F-A98D-864CC7511B23 wds:Q56974121-BF3D25EF-0AAC-4A90-ACB5-044F7269E395 wds:Q56974121-C9899814-7A63-42DF-AD8A-0148923DF1DF wds:Q56974121-F1CD58ED-503E-4625-8D60-CB0584788027
author name string	H S Thomsen P Junker K Stengaard-Pedersen A G Jurik A F Christensen I Hansen L S Andersen T Lottenburger U Tarp A Vestergaard CIMESTRA study group H Skjødt M Ostergaard E Narvestad B Ejbjerg J Vallø O Majgaard T Torfing
rdfs:label	MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA) (en) MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (nl)
skos:prefLabel	MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA) (en) MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (nl)
name	MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA) (en) MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (nl)
author	wds:Q56974121-040B251C-084F-4005-8CA1-685F8EF85C0B wds:Q56974121-0CFF2AF8-EB1B-4819-8CF0-9D9BD91620CD wds:Q56974121-4FD8E7DB-D6F6-45DB-9292-11ED60B34939 wds:Q56974121-8FBB12F4-6309-4BC8-8095-7311C544DA39 wds:Q56974121-CE10F468-7AFE-4D66-9201-B5B20E2FD82A wds:Q56974121-DE3DB31C-8D60-4D09-B004-EAA2CAE8AD27 wds:Q56974121-E57A3E69-5E20-48C9-8E7B-1EB0DB7E5DC7
author	Søren Jacobsen Kim Hørslev-Petersen Merete Lund Hetland Torkell Ellingsen Hanne Lindegaard Anders Svendsen Jens K Pedersen
title	wds:Q56974121-5DE938BF-6884-438C-B31E-CAC3D75ECF7B
title	MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA) (en)
page(s)	wds:Q56974121-15D406AB-DF5B-4CED-AE0B-08AF3013E4E1
page(s)	384-390
instance of	wds:Q56974121-66913EEB-5F86-4E68-A16C-A25BB6BB2AC2
instance of	scholarly article
main subject	wds:Q56974121-0479B459-C0DE-4AEE-8EAE-66BAC6C6960E wds:Q56974121-207CF5DA-9820-4D0B-8053-D558F333E5D0
main subject	rheumatoid arthritis magnetic resonance imaging
PubMed ID	wds:Q56974121-5A03B8D1-2A0B-4DBD-B8A9-8563A0DBE5DF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18388160
PubMed ID	18388160
published in	wds:Q56974121-CD5AD20B-EA21-421E-B9E6-9F07844FB5CE
published in	Annals of the Rheumatic Diseases
issue	wds:Q56974121-6A061AFD-D09C-45D6-BFD9-078F7F3B3995
volume	wds:Q56974121-7FA1ABB1-67ED-43BE-9AD4-A107C88C881E
issue	3
volume	68
DOI	wds:Q56974121-C1616E3D-D138-418F-B3C1-0975F0DCF5EF
DOI	http://dx.doi.org/10.1136/ARD.2008.088245
DOI	10.1136/ARD.2008.088245
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56974121
is cites work of	An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents Updating the OMERACT filter: implications for imaging and soluble biomarkers Subclinical synovitis detected by macrophage PET, but not MRI, is related to short-term flare of clinical disease activity in early RA patients: an exploratory study Osteoimmunology and osteoporosis Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis The changing face of rheumatoid arthritis: sustained remission for all? My treatment approach to rheumatoid arthritis Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double- Bone marrow edema and osteitis in rheumatoid arthritis: the imaging perspective Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software